Actionnariat et activité des initiés pour aTyr Pharma, Inc. (ATYR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.38 |
| Capitalisation | $38M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-05-27 | SCHIMMEL PAUL | P-Purchase | 100,000 | $50K |
| 2026-05-11 | Coughlin Timothy | A-Award | 50,000 | $48K |
| 2026-05-11 | BENEVICH ERIC | A-Award | 50,000 | $48K |
| 2026-05-11 | Gross Jane A | A-Award | 50,000 | $48K |
| 2026-05-11 | Lucas Svetlana | A-Award | 50,000 | $48K |
| 2026-05-11 | Zaknoen Sara | A-Award | 50,000 | $48K |
| 2026-05-11 | SCHIMMEL PAUL | A-Award | 50,000 | $48K |
| 2026-02-03 | Shukla Sanjay | M-Exempt | 10,375 | |
| 2026-02-04 | Shukla Sanjay | S-Sale | 3,745 | $4K |
| 2026-02-03 | Shukla Sanjay | M-Exempt | 10,375 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $38.4M | $21.1M | $23.0M | $9.2M | $17.0M | $2.3M | $10.0M | $22.5M | $11.1M | $10.7M |
| Placements à Court Terme | $33.8M | $64.0M | $26.6M | $21.9M | $14.7M | $105.6M | $56.2M | $75.6M | $61.1M | $67.9M |
| Créances | 0 | 0 | 0 | $100000 | $2.0M | $435000 | $11.8M | $2.4M | $1.7M | $873000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $74.8M | $87.0M | $50.8M | $31.9M | $35.5M | $113.6M | $80.9M | $103.0M | $82.0M | $80.2M |
| Immobilisations Corporelles | $1.4M | $2.3M | $1.9M | $4.1M | $3.0M | $1.8M | $11.6M | $14.0M | $11.9M | $10.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $80.5M | $89.4M | $52.7M | $36.2M | $38.7M | $115.5M | $95.8M | $120.7M | $96.8M | $94.2M |
| Dettes Fournisseurs | $2.6M | $2.3M | $1.0M | $847000 | $1.4M | $1.0M | $3.1M | $3.5M | $4.3M | $3.9M |
| Dette à Court Terme | $339000 | $5.0M | $7.8M | $8.7M | 0 | 0 | 0 | 0 | 0 | $1.5M |
| Passifs Courants | $8.5M | $10.4M | $10.8M | $12.9M | $5.9M | $6.0M | $13.9M | $16.4M | $15.0M | $15.1M |
| Dette à Long Terme | $9.2M | $14.7M | $8.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $17.7M | $25.1M | $19.1M | $15.2M | $7.2M | $6.4M | $24.5M | $30.2M | $27.0M | $26.9M |
| Réserves | -$216.0M | -$264.2M | -$298.7M | -$322.3M | -$338.5M | -$372.3M | -$417.6M | -$468.0M | -$532.0M | -$606.2M |
| Capitaux Propres | $62.8M | $64.2M | $33.6M | $21.2M | $31.6M | $109.3M | $71.5M | $90.7M | $70.0M | $67.5M |
| Dette Totale | $9.5M | $19.7M | $16.0M | $11.7M | $2.2M | $1.4M | $11.5M | $15.1M | $13.3M | $12.0M |
| Dette Nette | -$62.6M | -$65.4M | -$33.5M | -$19.4M | -$29.4M | -$106.5M | -$54.6M | -$83.1M | -$58.8M | -$66.7M |
| Fonds de Roulement | $66.2M | $76.6M | $40.0M | $19.0M | $29.7M | $107.6M | $67.0M | $86.6M | $67.0M | $65.1M |
Santé financière
| Dette / Capitaux propres | 0.23 |
| Ratio de liquidité | 5.12 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -9.28 |
Rentabilité
| Rentabilité des capitaux propres | -109.84% |
| Rentabilité du capital investi | -96.45% |
| Rentabilité des actifs | -78.71% |
| Marge brute | -11754.74% |
| Marge opérationnelle | -33609.47% |
| Marge nette | -32003.68% |
Entreprises liées: ACRV · ALXO · CAMP · DTIL · HYFT · MGX · QNCX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ATYR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions